About Phosphomannomutase 2
Phosphomannomutase 2 (PMM2) is a protein
from Homo sapiens identified by UniProt accession
O15305, 246 residues long.
MolForge cross-references it against 0 known binders and
154 disease associations.
Target properties
| Protein name | Phosphomannomutase 2 |
| UniProt accession | O15305 |
| Gene | PMM2 |
| Organism | Homo sapiens |
| Length | 246 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (154)
Diseases linked to this target (Open Targets).
- PMM2-congenital disorder of glycosylation · score 0.87
- congenital disorder of glycosylation · score 0.58
- SRD5A3-congenital disorder of glycosylation · score 0.55
- genetic disorder · score 0.54
- cerebellar ataxia · score 0.48
- isolated cerebellar hypoplasia/agenesis · score 0.48
- congenital disorder of glycosylation type I · score 0.45
- Intellectual disability · score 0.43
- cerebral palsy · score 0.42
- Poor speech · score 0.42
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O15305-F1 | alphafold | PREDICTED | 96.43 | — |
Amino-acid sequence (246 residues)
MAAPGPALCL FDVDGTLTAP RQKITKEMDD FLQKLRQKIK IGVVGGSDFE KVQEQLGNDV VEKYDYVFPE NGLVAYKDGK LLCRQNIQSH LGEALIQDLI NYCLSYIAKI KLPKKRGTFI EFRNGMLNVS PIGRSCSQEE RIEFYELDKK ENIRQKFVAD LRKEFAGKGL TFSIGGQISF DVFPDGWDKR YCLRHVENDG YKTIYFFGDK TMPGGNDHEI FTDPRTMGYS VTAPEDTRRI CELLFS
Explore Phosphomannomutase 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets